Syntaxin Limited
Records under this name other than the patents Syntaxin Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 9 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,293,230 | Transport protein which is used to introduce chemical compounds into nerve cells Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,481,040 | Carrier for targeting nerve cells Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,240,138 | Polypeptides That Bind to and Inhibit Secretion from Growth Hormone Secreting Cells Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,550,377 | Suppression of prostate cancer using a targeted clostridial neurotoxin Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,113,159 | Suppression of cancer Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,744,190 | Method for suppressing spasmodic torticollis Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,849,163 | Modified non-cytotoxic proteases Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,704,038 | Therapeutic fusion proteins Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,808,236 | Methods for the Manufacture of Proteolytically Processed Polypeptides Formerly held In force · High confidence | In force | High confidence | |
| US 11,441,141 | Methods for the Manufacture of Proteolytically Processed Polypeptides Formerly held In force · High confidence | In force | High confidence |